S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.28
+1.9%
$114.28
$89.67
$121.64
$186.15B0.745.69 million shs4.95 million shs
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$14.13
-0.4%
$15.64
$8.70
$19.74
$15.86B2.5432.08 million shs22.97 million shs
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$18.28
+0.6%
$18.70
$12.41
$22.75
$7.78B2.612.04 million shs7.43 million shs
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$128.49
+0.7%
$127.97
$59.37
$141.70
$32.98B2.522.72 million shs1.82 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.59%-5.52%-6.94%-8.26%-6.25%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
+0.39%-5.25%-11.82%-18.18%+44.69%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
+0.83%-2.42%-6.48%+2.31%+37.86%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
-0.26%-4.58%-1.37%+0.53%+97.98%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9951 of 5 stars
3.45.04.24.53.12.52.5
Carnival Co. & plc stock logo
CCL
Carnival Co. &
4.8676 of 5 stars
4.42.00.03.13.03.32.5
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
4.3178 of 5 stars
3.13.00.01.21.91.73.8
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
4.4935 of 5 stars
2.52.00.03.43.22.53.8

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.75
Moderate Buy$121.3113.08% Upside
Carnival Co. & plc stock logo
CCL
Carnival Co. &
2.80
Moderate Buy$21.4751.97% Upside
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
2.29
Hold$20.8714.15% Upside
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
2.94
Moderate Buy$136.946.58% Upside

Current Analyst Ratings

Latest CCL, RCL, NCLH, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/17/2024
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$164.00
4/11/2024
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$150.00 ➝ $154.00
4/9/2024
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
4/3/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $128.00
4/3/2024
Carnival Co. & plc stock logo
CCL
Carnival Co. &
Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$23.00 ➝ $25.00
4/1/2024
Carnival Co. & plc stock logo
CCL
Carnival Co. &
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $20.00
4/1/2024
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/28/2024
Carnival Co. & plc stock logo
CCL
Carnival Co. &
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $25.00
3/28/2024
Carnival Co. & plc stock logo
CCL
Carnival Co. &
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$22.00 ➝ $24.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.64$6.44 per share16.65$22.36 per share4.80
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$21.59B0.73$2.26 per share6.24$5.95 per share2.37
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$8.55B0.91$2.53 per share7.22$0.71 per share25.75
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$13.90B2.37$13.29 per share9.67$19.12 per share6.72

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.4220.872.5513.96%20.32%10.59%7/18/2024 (Estimated)
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-$75M$0.2654.359.81N/A1.79%7.75%1.02%6/24/2024 (Estimated)
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$166.18M$0.2865.2913.250.381.94%108.69%0.94%5/1/2024 (Confirmed)
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$1.70B$6.2220.6610.940.4712.22%45.55%5.47%4/25/2024 (Confirmed)

Latest CCL, RCL, NCLH, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$0.1210N/A-$0.1210N/AN/AN/A  
4/25/2024N/A
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$1.30N/A-$1.30N/AN/AN/A  
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
3/27/2024Q1 24
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-$0.18-$0.14+$0.04-$0.11$5.42 billion$5.41 billion      
2/27/2024Q4 23
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
-$0.13-$0.18-$0.05-$0.21$1.99 billion$1.99 billion    
2/1/2024Q4 23
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$1.13$1.25+$0.12$1.44$3.36 billion$3.33 billion    
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
Carnival Co. & plc stock logo
CCL
Carnival Co. &
N/AN/AN/AN/AN/A
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
N/AN/AN/AN/AN/A
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
N/AN/AN/AN/AN/A

Latest CCL, RCL, NCLH, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Carnival Co. & plc stock logo
CCL
Carnival Co. &
4.27
0.36
0.32
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
40.94
0.22
0.19
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
4.03
0.19
0.16

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
67.19%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
69.58%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
87.53%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
11.00%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
0.87%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
8.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Carnival Co. & plc stock logo
CCL
Carnival Co. &
92,0001.12 billion998.87 millionOptionable
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
41,000425.66 million421.95 millionOptionable
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
98,200256.68 million234.35 millionOptionable

CCL, RCL, NCLH, and ABT Headlines

SourceHeadline
Federated Hermes Inc. Increases Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)Federated Hermes Inc. Increases Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)
marketbeat.com - April 19 at 8:27 AM
Royal Caribbean Cruises (NYSE:RCL) Now Covered by MizuhoRoyal Caribbean Cruises (NYSE:RCL) Now Covered by Mizuho
americanbankingnews.com - April 19 at 1:58 AM
Mackenzie Financial Corp Has $23.12 Million Stake in Royal Caribbean Cruises Ltd. (NYSE:RCL)Mackenzie Financial Corp Has $23.12 Million Stake in Royal Caribbean Cruises Ltd. (NYSE:RCL)
marketbeat.com - April 18 at 6:40 AM
Royal Caribbean Cruises (RCL) to Release Earnings on ThursdayRoyal Caribbean Cruises (RCL) to Release Earnings on Thursday
americanbankingnews.com - April 18 at 3:22 AM
Mizuho Initiates Coverage of Royal Caribbean Cruises (RCL) with Buy RecommendationMizuho Initiates Coverage of Royal Caribbean Cruises (RCL) with Buy Recommendation
msn.com - April 17 at 5:35 PM
Mizuho Begins Coverage on Royal Caribbean Cruises (NYSE:RCL)Mizuho Begins Coverage on Royal Caribbean Cruises (NYSE:RCL)
marketbeat.com - April 17 at 3:38 PM
Royal Caribbean Cruises Has Upside To Estimates, Says Bullish AnalystRoyal Caribbean Cruises Has Upside To Estimates, Says Bullish Analyst
markets.businessinsider.com - April 17 at 12:35 PM
Wyndham Hotels (WH) Enhances Business Travel SolutionsWyndham Hotels (WH) Enhances Business Travel Solutions
finance.yahoo.com - April 17 at 12:35 PM
Zacks Value Investor Highlights: JD.com, Owens Corning, Royal Caribbean Cruises, Toyota Motor and Pilgrims PrideZacks Value Investor Highlights: JD.com, Owens Corning, Royal Caribbean Cruises, Toyota Motor and Pilgrim's Pride
finance.yahoo.com - April 17 at 7:35 AM
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)
marketbeat.com - April 17 at 4:44 AM
Royal Caribbean Gr Unusual Options Activity For April 16Royal Caribbean Gr Unusual Options Activity For April 16
benzinga.com - April 16 at 4:34 PM
Despite shrinking by US$2.9b in the past week, Royal Caribbean Cruises (NYSE:RCL) shareholders are still up 101% over 1 yearDespite shrinking by US$2.9b in the past week, Royal Caribbean Cruises (NYSE:RCL) shareholders are still up 101% over 1 year
finance.yahoo.com - April 16 at 11:33 AM
Royal Caribbean Cruises Ltd. (RCL) is Attracting Investor Attention: Here is What You Should KnowRoyal Caribbean Cruises Ltd. (RCL) is Attracting Investor Attention: Here is What You Should Know
zacks.com - April 16 at 10:05 AM
Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?
marketbeat.com - April 16 at 6:17 AM
NewEdge Wealth LLC Invests $1.29 Million in Royal Caribbean Cruises Ltd. (NYSE:RCL)NewEdge Wealth LLC Invests $1.29 Million in Royal Caribbean Cruises Ltd. (NYSE:RCL)
marketbeat.com - April 16 at 6:15 AM
Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean? (RCL)Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean? (RCL)
marketbeat.com - April 16 at 6:15 AM
RCL vs. ATAT: Which Stock Is the Better Value Option?RCL vs. ATAT: Which Stock Is the Better Value Option?
finance.yahoo.com - April 15 at 12:54 PM
Nerdys (NRDY) Varsity Tutors for Schools Collabs with Prague HSNerdy's (NRDY) Varsity Tutors for Schools Collabs with Prague HS
finance.yahoo.com - April 15 at 12:54 PM
RCL vs. ATAT: Which Stock Is the Better Value Option?RCL vs. ATAT: Which Stock Is the Better Value Option?
zacks.com - April 15 at 12:46 PM
How Royal Caribbean is leading the charge in the cruise industry comebackHow Royal Caribbean is leading the charge in the cruise industry comeback
cnbc.com - April 15 at 11:00 AM
Why Royal Caribbean (RCL) is a Top Value Stock for the Long-TermWhy Royal Caribbean (RCL) is a Top Value Stock for the Long-Term
zacks.com - April 15 at 10:46 AM
Royal Caribbean quietly fixes 3 big passenger pain pointsRoyal Caribbean quietly fixes 3 big passenger pain points
msn.com - April 14 at 12:58 PM
I Just Took a 3-Night Royal Caribbean Cruise -- Heres What I Loved, and What I DidntI Just Took a 3-Night Royal Caribbean Cruise -- Here's What I Loved, and What I Didn't
fool.com - April 14 at 12:58 PM
Allspring Global Investments Holdings LLC Boosts Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)Allspring Global Investments Holdings LLC Boosts Stock Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)
marketbeat.com - April 13 at 6:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Carnival Co. & logo

Carnival Co. &

NYSE:CCL
Carnival Corporation & plc engages in the provision of leisure travel services in North America, Australia, Europe, Asia, and internationally. The company operates through four segments: NAA Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Other. It operates port destinations, private islands, and a solar park, as well as owns and operates hotels, lodges, glass-domed railcars, and motor coaches. The company offers its services under the Carnival Cruise Line, Princess Cruises, Holland America Line, Seabourn, Costa Cruises, AIDA Cruises, P&O Cruises, and Cunard brand. Additionally, it sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.
Norwegian Cruise Line logo

Norwegian Cruise Line

NYSE:NCLH
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. Norwegian Cruise Line Holdings Ltd. was founded in 1966 and is based in Miami, Florida.
Royal Caribbean Cruises logo

Royal Caribbean Cruises

NYSE:RCL
Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 21, 2024, it operated 65 ships. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida.